Back to School: How biopharma can reboot drug development. Access exclusive analysis here

1016 TIB preclin QT
BioCentury & Getty Images

Translation in Brief

SARS-CoV-2 infects brain choroid plexus, compromises CSF-blood barrier; plus Passage’s GM1 gangliosidosis gene therapy, a new COVID-19 reporter and more

BioCentury’s roundup of translational news

BioCentury’s roundup of translational news.

Oct 17, 2020 | 2:12 AM GMT

SARS-CoV-2 infects brain choroid plexus
A team from Medical Research Council Laboratory

Read the full 547 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE